Triple

T22693652
Position Surface form Disambiguated ID Type / Status
Subject Tiglutik E561111 entity
Predicate indicationDetail P113308 FINISHED
Object treatment of patients with amyotrophic lateral sclerosis to extend survival or time to tracheostomy LITERAL FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: treatment of patients with amyotrophic lateral sclerosis to extend survival or time to tracheostomy | Statement: [Tiglutik, indicationDetail, treatment of patients with amyotrophic lateral sclerosis to extend survival or time to tracheostomy]
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: indicationDetail
Context triple: [Tiglutik, indicationDetail, treatment of patients with amyotrophic lateral sclerosis to extend survival or time to tracheostomy]
  • A. treatmentIndication chosen
    Indicates that a treatment is intended to address, alleviate, or prevent a particular condition, symptom, or medical indication.
  • B. indicationOfProduct
    Indicates that something serves as evidence, a sign, or a marker pointing to the existence, presence, or relevance of a particular product.
  • C. indicationRegion
    Indicates that something serves as a sign, marker, or signal specifically associated with a particular geographic or spatial region.
  • D. hasIndication
    Indicates that one entity (typically a product, treatment, or intervention) is intended, approved, or suitable for use in addressing, preventing, or managing a particular condition, purpose, or circumstance.
  • E. indicatedFor
    Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).
  • F. None of above.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454d71b48190a1f80af9f82b6fcf completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1789c6ae481908975b7d27e7624ac completed April 29, 2026, 3:18 a.m.
PD Predicate disambiguation batch_69ee62b2259c819091ed1387a748b9f3 completed April 26, 2026, 7:08 p.m.
Created at: April 17, 2026, 3:13 p.m.